Zobrazeno 1 - 10
of 22
pro vyhledávání: '"365"'
Autor:
Axel C.P. Diederichsen, Jes S. Lindholt, Sören Möller, Kristian A. Øvrehus, Søren Auscher, Jess Lambrechtsen, Susanne E. Hosbond, Dilek H. Alan, Grazina Urbonaviciene, Søren W. Becker, Maise H. Fredgart, Selma Hasific, Lars Folkestad, Oke Gerke, Lars Melholt Rasmussen, Jacob E. Møller, Hans Mickley, Jordi S. Dahl
Publikováno v:
Diederichsen, A C P, Lindholt, J S, Möller, S, Øvrehus, K A, Auscher, S, Lambrechtsen, J, Hosbond, S E, Alan, D H, Urbonaviciene, G, Becker, S W, Fredgart, M H, Hasific, S, Folkestad, L, Gerke, O, Rasmussen, L M, Møller, J E, Mickley, H & Dahl, J S 2022, ' Vitamin K2 and D in Patients With Aortic Valve Calcification : A Randomized Double-Blinded Clinical Trial ', Circulation, vol. 145, no. 18, pp. 1387-1397 . https://doi.org/10.1161/CIRCULATIONAHA.121.057008
Background: Menaquinone-7 (MK-7), also known as vitamin K2, is a cofactor for the carboxylation of proteins involved in the inhibition of arterial calcification and has been suggested to reduce the progression rate of aortic valve calcification (AVC)
Autor:
Nicole Jaeger, Marc P. Bonaca, Mark R. Nehler, David Szalay, Henrik Sillesen, Sonia S. Anand, Taylor Brackin, Connie N. Hess, Eva Muehlhofer, Eike Sebastian Debus, William R. Hiatt, David Brasil, Rupert Bauersachs, Warren H. Capell, Manesh R. Patel, Lloyd Haskell, Akos F. Pap, Juraj Madaric, Scott D. Berkowitz
Publikováno v:
Circulation. 142:2219-2230
Background: The VOYAGER PAD trial (Vascular Outcomes Study of ASA Along With Rivaroxaban in Endovascular or Surgical Limb Revascularization for Peripheral Artery Disease) demonstrated superiority of rivaroxaban plus aspirin versus aspirin to reduce m
Autor:
Iqwal Mangat, Anthony Tang, Marc W. Deyell, Christian Steinberg, John L. Sapp, Marc Dubuc, Matthew T. Bennett, Mariano Badra-Verdu, Jean Champagne, Clarence Khoo, Paul Khairy, Paul Novak, Atul Verma, Peter Leong-Sit, Laurent Macle, Jason G. Andrade
Publikováno v:
Circulation. 140:1779-1788
Background: Advanced generation ablation technologies have been developed to achieve more effective pulmonary vein isolation (PVI) and minimize arrhythmia recurrence after atrial fibrillation (AF) ablation. Methods: We randomly assigned 346 patients
Autor:
E A, Bocchi, G, Bellotti, A, Vilella de Moraes, F, Bacal, L F, Moreira, A, Esteves-Filho, J T, Fukushima, G, Guimarães, N, Stolf, A, Jatene, F, Pileggi
Publikováno v:
Circulation. 96
Left ventricular partial ventriculectomy (LVPV), an unconventional operation to reverse some aspects of the cardiac remodeling, has been proposed for treatment of congestive heart failure.Twenty-four patients (age 46+/-9 years) referred to heart tran
Autor:
Roderick Tung, Gaurav A. Upadhyay, Zaid Aziz, Hemal M. Nayak, Andrew D. Beaser, Takuro Nishimura, Dalise Y. Shatz
Publikováno v:
Circulation. 143(3)
Background: Fast ventricular tachycardias (VTs) have historically been attributed to shorter path lengths with smaller reentrant circuit dimensions in animal models. The relationship between the dimensions of the reentrant VT circuit and tachycardia
Autor:
Yongjun Wang, Valery L. Feigin, Shengping Wu, Bin Jiang, Yong Jiang, Limin Wang, Yichong Li, Wenzhi Wang, Yilong Wang, Haixin Sun, Yazhuo Zhang, Linhong Wang, Xiaojuan Ru, David Wang, Zhenghong Chen, Dongling Sun
Publikováno v:
Circulation. 135:759-771
Background: China bears the biggest stroke burden in the world. However, little is known about the current prevalence, incidence, and mortality of stroke at the national level, and the trend in the past 30 years. Methods: In 2013, a nationally repres
Autor:
Mayil S. Krishnam, Matthew J. Budoff, Thomas Mayrhofer, Maros Ferencik, Udo Hoffmann, Pamela S. Douglas, Michael T. Lu, Kerry L. Lee, Daniel O. Bittner, Adrian Coles, James J. Jang
Publikováno v:
Circulation. 136(21)
Background: Coronary artery calcium (CAC) is an established predictor of future major adverse atherosclerotic cardiovascular events in asymptomatic individuals. However, limited data exist as to how CAC compares with functional testing (FT) in estima
Autor:
Prakash Krishnan, Peter Faries, Khusrow Niazi, Ash Jain, Ravish Sachar, William B. Bachinsky, Joseph Cardenas, Martin Werner, Marianne Brodmann, J. A. Mustapha, Carlos Mena-Hurtado, Michael R. Jaff, Andrew H. Holden, Sean P. Lyden, Mark Mewissen, Barry Katzen, Aravinda Nanjundappa, Matheen A. Khuddus, Jason Ricci, Dennis Fry, Mehdi Shishehbor, Christopher Bosarge, Richard Kovach, Mark Goodwin, Mohammad Laiq Raja, Guy Mayeda, Jasvinder Sandhu, Oscar Rosales, William Crowder, David Paolini, John Henretta, Pratik Desai, Naim Farhat, Edward Kang, Gary Ansel, Mohammad Ghani, William Miller, Christopher Pollock, Ethan Korngold, John F. Angle, Greg Schultz, Todd Gensler, Louis Lopez, James Park, Georges Al-Khoury, Charles Joels, Christopher Metzger
Publikováno v:
Circulation
Supplemental Digital Content is available in the text.
Background: Drug-coated balloons (DCBs) are a predominant revascularization therapy for symptomatic femoropopliteal artery disease. Because of the differences in excipients, paclitaxel dose,
Background: Drug-coated balloons (DCBs) are a predominant revascularization therapy for symptomatic femoropopliteal artery disease. Because of the differences in excipients, paclitaxel dose,
Autor:
Barry A. Franklin
Publikováno v:
Circulation. 129:1081-1084
Physical inactivity is a serious health problem worldwide, contributing to early development of obesity, diabetes mellitus, hypertension, and cardiovascular diseases (CVD).1 In fact, our hypokinetic lifestyle is now widely recognized among the most p
Autor:
Rhodes, CJ, Ghataorhe, P, Wharton, J, Rue-Albrecht, KC, Hadinnapola, C, Watson, G, Bleda, M, Haimel, M, Coghlan, G, Corris, PA, Howard, LS, Kiely, DG, Peacock, AJ, Pepke-Zaba, J, Toshner, MR, Wort, SJ, Gibbs, JSR, Lawrie, A, Gräf, S, Morrell, NW, Wilkins, MR
Publikováno v:
Circulation
Supplemental Digital Content is available in the text.
Background: Pulmonary arterial hypertension (PAH) is a heterogeneous disorder with high mortality. Methods: We conducted a comprehensive study of plasma metabolites using ultraperformance li
Background: Pulmonary arterial hypertension (PAH) is a heterogeneous disorder with high mortality. Methods: We conducted a comprehensive study of plasma metabolites using ultraperformance li